Portugal Bioinformatics Market Analysis Report [2022-30] I Insights10

Portugal Bioinformatics Market Analysis

$ 3999

The Portugal Bioinformatics market is projected to grow from $46.05 Mn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be advancements in technologies and growing innovations in the healthcare industry. The market is segmented by technology and by application. Some of the major players include Ophiomics (PRT), GeneConnect (PRT), Agilent Technologies, IBM Life Sciences, and Eurofins Scientific.

ID: IN10PTHS001 CATEGORY: Healthcare Services GEOGRAPHY: Portugal AUTHOR: Neha Davda

Buy Now

Portugal Bioinformatics Market Executive Summary

The Portugal Bioinformatics market is projected to grow from $46.05 Mn in 2022 to $XX Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. In, 2019, the national health expenditure in Portugal was 9.53% of its GDP. Portugal has long had lower health spending per person and as a percentage of GDP than the rest of the EU. Portugal spent $2,221 per person on health in 2019, which is a third less than the EU average.

Bioinformatics is a field of research that combines biology and information technology. The techniques utilized in bioinformatics include data production, data warehousing, data mining, data management, and others. For applications like next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery, bioinformatics software and tools are employed as integrated solutions to provide statistical approaches and data processing algorithms. Europe has the second-largest market share in the world's bioinformatics market. The second-largest market share in the world for bioinformatics is held by the European continent.

portugal bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The Portugal bioinformatics market is expected to be driven by factors such as advancements in technologies and growing innovations in the healthcare industry. The World Index of Healthcare Innovation places Portugal in 17th place, up from 21st in 2020, with a total score of 46.92.

Market Restraints

Lack of standardization and the high cost of research and development of bioinformatics tools and software limits the growth of the bioinformatics market in Portugal.

Competitive Landscape

Key Players

Ophiomics (PRT)
GeneConnect (PRT)
Agilent Technologies
IBM Life Sciences
Eurofins Scientific

Notable Recent Deals

February 2022: Ophiomics entered into a collaboration with Biocartis Group NV, an innovative molecular diagnostics company. This collaboration focuses on the commercialization of HepatoPredict, a predictive gene expression signature test to assist in determining which individuals may benefit from surgical procedures with the goal of curing disease, particularly liver transplantation.

Healthcare Policies and Regulatory Landscape

The National Health Service (SNS), which is publicly funded and aspires to offer universal access to healthcare services, administers Portugal's healthcare system. The Ministry of Health, which establishes guidelines and rules for the nation's healthcare systems, oversees the SNS.

In Portugal, both public and private healthcare service providers are allowed to operate under the country's mixed public-private healthcare model. All citizens are entitled to free access to public healthcare services, although those with sufficient financial means can also obtain private treatment.

The National Authority of Medicines and Health Products, which is in charge of guaranteeing that all medications and medical devices on the market are safe and effective, regulates healthcare services in Portugal. The authority also keeps an eye on the quality of medical care delivered in the nation and makes sure that healthcare workers are qualified and adhere to the required standards.

Reimbursement Scenario

The National Health Service of Portugal sets the reimbursement guidelines for medical treatments (SNS). For citizens and legal residents, the SNS pays for the majority of healthcare expenses, such as hospital stays, doctor visits, and prescription medications. Co-payments or other charges might be necessary for some goods or medications, though.

Drugs and medical equipment that are deemed essential and are fully covered by the government are listed in the SNS. But not all medications and medical equipment are covered by the SNS, and some can cost the patient more money. Furthermore, private healthcare reimbursement procedures could be different from public healthcare procedures. The payment for private healthcare providers' services may vary depending on the contracts they have with health insurance providers or other payers.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.